EOCRU was established in 2008 by a memorandum of understanding between the Eijkman Institute for Molecular Biology (EIMB) and the University of Oxford, as an embedded unit of the EIMB. These institutions now collaborate in clinical, laboratory, and field research on infectious diseases of public health importance in Indonesia. EOCRU is directed by Prof J. Kevin Baird and comprises three research groups and five supporting service groups.
The Eijkman-Oxford Clinical Research Unit (EOCRU), with its Indonesian hosts and partners, aims to collaboratively develop and pursue a research agenda of relevance to Indonesian healthcare providers and their patients. We are especially committed to infectious diseases that impose burdens of preventable or treatable morbidity and mortality in Southeast Asia, including tuberculosis, malaria, and other emerging and neglected infections. EOCRU’s vision is to compose an important and highly active centre of biomedical research excellence, with our hosts and partners, focusing on opportunities to improve the prevention, diagnosis, and treatment of these endemic infections by conducting robust randomized clinical trials that may directly impact practice and improve the health outcomes in Indonesia and the region.
Lenny Lia Ekawati, University of Oxford; Iqbal Elyazar, Eijkman-Oxford Clinical Research Unit (EOCRU); Tety Rachmawati, National Institute of Health Research and Development (NIHRD), Ministry of Health Indonesia, and Wahyu Pudji Nugraheni, National Institute of Health Research and Development (NIHRD), Ministry of Health Indonesia
Individu, keluarga, masyarakat dan pengambil kebijakan bersama-sama mencegah risiko kematian dengan mengubah perilaku, pola konsumsi, dan membelanjakan anggaran untuk menunjang hidup sehat.